Stroke Progress Review Group sets priorities for future NIH stroke rehabilitation research

In 2011, the National Institute of Neurological Disorders and Stroke (NINDS) convened the Stroke Progress Review Group (SPRG) to conduct a final 10-year review of the state of stroke research. The goal is to set priorities and shape future NINDS programs and policies. While SPRG found much available data for maximizing stroke rehabilitation outcomes, translation to clinical practice is inadequate. To realize the enormous potential for improving rehabilitation and recovery, more resources should be applied to implementing and directly supporting SPRG's recommendations.

The Final Report of the Stroke PRG is on the NINDS SPRG website: http://www.ninds.nih.gov/find_people/groups/stroke_prg/01-2012-stroke-prg-report.htm.

The working group for rehabilitation and recovery was co-chaired by Anna Barrett, MD, director of Research at Kessler Foundation, Pamela Duncan, PT, PhD, Duke Center for Clinical , with Steven C. Cramer, MD (NINDS liaison co-chair). "The strategic plan and vision set out in the 2002 SPRG was intended for ten-year implementation," said Dr. Barrett. "To assess progress in rehabilitation and recovery, we recruited eleven working group members (John Chae, Leonardo Cohen, Bruce Crosson, Leigh Hochberg, Rebecca Ichord, Albert Lo, Randy Nudo, Randall Robey, R. Jarrett Rushmore, Sean Savitz, and Robert Teasell with assistance from Norine Foley)."

The working group found significant advances at ten-year followup. "Not only have we addressed the original SPRG priorities (eg, improving stroke deficits, rather than advising compensatory management), noted Dr Barrett, "we have pushed the science of rehabilitation much further forward. For example, the report cites NIH-funded work done at Kessler Foundation using optical prism training to rehabilitate hidden disabilities of functional vision after right brain stroke. This concept of targeting any treatment to a specific had not yet been funded by the NIH ten years ago. Now we need to apply these strategies over large patient groups, since the number of US stroke survivors continues to rise."

Three priorities were identified:

  1. Need for studies identifying valid, reliable, affordable, and accessible measurements of neuroplasticity. We need to understand how these measures of brain plasticity can be used to guide and individualize rehabilitation/restorative therapies to achieve optimal outcomes among all persons affected by stroke.
  2. Substantial data suggest that brain plasticity after stroke is shaped by experience. We need to determine which experiences are most important, what dose of experience is needed to maximize outcomes, and how to measure these experiences. An improved understanding of biomarkers of recovery and restorative therapies will support achieving these goals.
  3. Advances in basic science of brain repair indicate a major opportunity for translating new restorative therapies to address post-stroke disability. Delivery of appropriate treatment requires a team effort, from bench to bedside to health policy reform. Implementation of Specialized Programs of Translational Stroke Research in Recovery (SPOTS-R2) is a priority.
"This report and the top 3 priorities will form a crucial component of the second phase of our stroke planning process where we will identify the highest priority research goals in each of the major areas of prevention, treatment and recovery," commented NINDS director Story Landis, PhD.

add to favorites email to friend print save as pdf

Related Stories

What are the long term outcomes following stroke?

May 17, 2011

Despite the recognition of stroke as a major contributor to disability and mortality worldwide, little is known about the long-term outcomes among individuals who survive a stroke. In a research study reported by Charles ...

Not a moment to lose in therapy for acute stroke

Sep 24, 2008

In an editorial response to a report in the September 25 issue of the New England Journal of Medicine on the efficacy of intravenous thrombolysis treatment in the hours after acute ischemic stroke, Patrick Lyden, M.D., profes ...

Recommended for you

Adrenal sex hormone level may predict heart disease risk

11 hours ago

(HealthDay)—Blood levels of the adrenal sex hormone dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S) may predict an increased risk of coronary heart disease (CHD) in elderly men, according to a study ...

Researchers aim to simplify life saving drug

Oct 29, 2014

Heparin, the life saving blood thinner used in major surgeries and treatment of heart diseases, is a complicated drug but a research team from the University of British Columbia has set out to make its use a lot safer by ...

Frequent readmissions, high costs after cardiac arrest

Oct 29, 2014

(HealthDay)—Frequent readmissions and high inpatient costs are seen among older survivors of in-hospital cardiac arrest, according to a study published online Oct. 28 in Circulation: Cardiovascular Quality an ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.